Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Study Group, NORDynamIC"'
Autor:
Lagging, Martin, Langeland, Nina, Pedersen, Court, Färkkilä, Martti, Buhl, Mads Rauning, Mørch, Kristine, Dhillon, Amar P, Alsiö, Asa, Hellstrand, Kristoffer, Westin, Johan, Christensen, Peer, Leutscher, Peter, Norkrans, Gunnar, Study Group, NORDynamIC
Publikováno v:
Lagging, M, Langeland, N, Pedersen, C, Färkkilä, M, Buhl, M R, Mørch, K, Dhillon, A P, Alsiö, A, Hellstrand, K, Westin, J, Christensen, P, Leutscher, P, Norkrans, G & Study Group, NORDC 2008, ' Weight-adjusted dosing of ribavirin and importance of hepatitis C virus RNA below 1000 IU/mL by day 7 in short-term peginterferon therapy for chronic genotype 2/3 hepatitis C virus infection ', Hepatology, vol. 48, no. 2, pp. 695 . https://doi.org/10.1002/hep.22450
Lagging, M, Langeland, N, Pedersen, C, Färkkilä, M, Buhl, M R, Mørch, K, Dhillon, A P, Alsiö, A, Hellstrand, K, Westin, J, Christensen, P, Leutscher, P, Norkrans, G & NORDynamIC Study Group 2008, ' Weight-adjusted dosing of ribavirin and importance of hepatitis C virus RNA below 1000 IU/mL by day 7 in short-term peginterferon therapy for chronic genotype 2/3 hepatitis C virus infection ', Hepatology, vol. 48, no. 2, pp. 695 . https://doi.org/10.1002/hep.22450
Lagging, M, Langeland, N, Pedersen, C, Färkkilä, M, Buhl, M R, Mørch, K, Dhillon, A P, Alsiö, A, Hellstrand, K, Westin, J, Christensen, P, Leutscher, P, Norkrans, G & NORDynamIC Study Group 2008, ' Weight-adjusted dosing of ribavirin and importance of hepatitis C virus RNA below 1000 IU/mL by day 7 in short-term peginterferon therapy for chronic genotype 2/3 hepatitis C virus infection ', Hepatology, vol. 48, no. 2, pp. 695 . https://doi.org/10.1002/hep.22450
Udgivelsesdato: 2008-Jul-29
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee20524e2f2cb8aa77e214dd5c572dde
https://portal.findresearcher.sdu.dk/da/publications/8022bce0-62f6-11dd-b1a1-000ea68e967b
https://portal.findresearcher.sdu.dk/da/publications/8022bce0-62f6-11dd-b1a1-000ea68e967b
Autor:
Lagging, Martin, Langeland, Nina, Pedersen, Court, Färkkilä, Martti, Buhl, Mads Rauning, Mørch, Kristine, Dhillon, Amar P, Alsiö, Asa, Hellstrand, Kristoffer, Westin, Johan, Norkrans, Gunnar, Study Group, NORDynamIC
Publikováno v:
Lagging, M, Langeland, N, Pedersen, C, Färkkilä, M, Buhl, M R, Mørch, K, Dhillon, A P, Alsiö, A, Hellstrand, K, Westin, J, Norkrans, G & Study Group, NORDC 2008, ' Randomized comparison of 12 or 24 weeks of peginterferon alpha-2a and ribavirin in chronic hepatitis C virus genotype 2/3 infection ', Hepatology, vol. 47, no. 6, pp. 1837-1845 . https://doi.org/10.1002/hep.22253
Lagging, M, Langeland, N, Pedersen, C, Färkkilä, M, Buhl, M R, Mørch, K, Dhillon, A P, Alsiö, A, Hellstrand, K, Westin, J, Norkrans, G & NORDynamIC Study Group 2008, ' Randomized comparison of 12 or 24 weeks of peginterferon alpha-2a and ribavirin in chronic hepatitis C virus genotype 2/3 infection ', Hepatology, vol. 47, no. 6, pp. 1837-45 . https://doi.org/10.1002/hep.22253
Lagging, M, Langeland, N, Pedersen, C, Färkkilä, M, Buhl, M R, Mørch, K, Dhillon, A P, Alsiö, A, Hellstrand, K, Westin, J, Norkrans, G & NORDynamIC Study Group 2008, ' Randomized comparison of 12 or 24 weeks of peginterferon alpha-2a and ribavirin in chronic hepatitis C virus genotype 2/3 infection ', Hepatology, vol. 47, no. 6, pp. 1837-45 . https://doi.org/10.1002/hep.22253
Udgivelsesdato: 2008-Jun Previous trials investigating the efficacy of treatment durations shorter than the standard of 24 weeks for chronic hepatitis C virus (HCV) genotype 2/3 infections have yielded discordant results. The aims of this investigato
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1801e840d422d54aca3fbb0509653e33
https://portal.findresearcher.sdu.dk/da/publications/17d3ca20-4222-11dd-9fbe-000ea68e967b
https://portal.findresearcher.sdu.dk/da/publications/17d3ca20-4222-11dd-9fbe-000ea68e967b